SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001178913-16-005577
Filing Date
2016-05-31
Accepted
2016-05-31 08:01:19
Documents
9
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A zk1618553.htm 20-F/A 75329
2 EXHIBIT 4.33 exhibit_4-33.htm EX-4.33 502500
3 EXHIBIT 4.40 exhibit_4-40.htm EX-4.40 276270
4 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 15519
5 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 15318
6 bioline2.jpg GRAPHIC 5131
7 image0.jpg GRAPHIC 1910
8 image1.jpg GRAPHIC 829
9 image2.jpg GRAPHIC 665
  Complete submission text file 0001178913-16-005577.txt   898279
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-35223 | Film No.: 161683950
SIC: 2834 Pharmaceutical Preparations